December 16, 2025

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 51% Upside Potential in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, specifically in the medical devices industry, has captured investor interest with an impressive potential upside of 51.27%. As..

BioLife Solutions, Inc. (BLFS): Investor Outlook Reveals 30% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) stands as a pivotal player in the healthcare sector, specifically in the medical instruments and supplies industry. With its headquarters in Bothell, Washington, the company..

Kestra Medical Technologies (KMTS): Investor Outlook with a 53.4% Revenue Growth Amid a Promising Upside

As the healthcare sector continues to evolve with technological advancements, Kestra Medical Technologies, Ltd. (KMTS) emerges as a noteworthy player with its innovative approach in the medical instruments and supplies..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating a Challenging Landscape with Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, is navigating a complex yet potentially rewarding landscape. As a leader in the medical care facilities industry,..

Mineralys Therapeutics, Inc. (MLYS) Investor Outlook: A 37.77% Potential Upside in Biotechnology

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) presents a compelling opportunity for investors with a notable potential upside of 37.77%. With a current market cap of $2.85 billion, this Radnor, Pennsylvania-based biotechnology..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Evaluating an 82.66% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) may not currently be the most glamorous name in the stock market, but with a potential upside of 82.66%, investors looking for opportunities in the..

Disc Medicine, Inc. (IRON) Stock Analysis: A Promising 30% Upside in the Biotech Sector

For individual investors with a keen interest in the biotechnology sector, Disc Medicine, Inc. (NASDAQ: IRON) presents an intriguing opportunity. With a market capitalization of $3.47 billion, this clinical-stage biopharmaceutical..

Dyne Therapeutics Inc. (DYN) Stock Analysis: Unpacking a Potential 98% Upside in Biotech Innovation

Dyne Therapeutics, Inc. (NASDAQ: DYN), a burgeoning player in the biotechnology sector, is gaining traction among investors seeking promising opportunities in the healthcare industry. With a market capitalization of $3.28..

89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 104.68% Upside in the Biotech Arena

Investors with an eye for innovation in the healthcare sector may find 89bio, Inc. (NASDAQ: ETNB) a compelling addition to their portfolios. As a clinical-stage biopharmaceutical company, 89bio is at..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 15% Potential Upside Amidst Mixed Financial Metrics

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the healthcare sector, specifically within the medical devices industry, presents a fascinating scenario for investors. With a market capitalization of..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Assessing a 25.25% Potential Upside in the Medical Instruments Sector

For investors looking to dive into the healthcare sector, LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing proposition. Specializing in the development and marketing of medical devices for vascular surgery,..

CG Oncology, Inc. (CGON) Stock Analysis: A 77.90% Potential Upside with Promising Clinical Trials

CG Oncology, Inc. (NASDAQ: CGON), a pioneering name in the biotechnology sector, has made significant strides in developing bladder cancer therapies. With a market capitalization of $3.21 billion, the company’s..

Denali Therapeutics (DNLI) Rating Update: Exploring an 85% Potential Upside in Neurodegenerative Treatments

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline of treatments targeting neurodegenerative and lysosomal storage diseases. Based in..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: A Compelling 59% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, has caught the attention of investors with a substantial market cap of $2.53 billion and a compelling potential..

Harrow, Inc. (HROW) Stock Analysis: A 54.54% Potential Upside Ignites Investor Interest

For investors with an eye on the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents a compelling opportunity. Specializing in ophthalmic pharmaceuticals, Harrow has shown significant promise with a potential upside..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Promising 44% Upside in Biotech Innovation

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is gaining attention in the biotech sector, reflecting a compelling opportunity for investors intrigued by innovative healthcare solutions. With its robust market capitalization of $3.87..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 19.80% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a prominent player in the healthcare industry, has positioned itself as a pivotal provider of home-based healthcare services. With a market capitalization of $1.86..

Surgery Partners, Inc. (SGRY) Investor Outlook: Exploring a Potential 66% Upside

Surgery Partners, Inc. (SGRY), listed on the U.S. healthcare sector under the medical care facilities industry, stands out for its potential upside of 66.63% according to analyst ratings. With a..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 20.54% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, presents a promising investment opportunity with a potential upside of 20.54%. As a specialized drug manufacturer in both..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings Signal Potential 27.52% Upside for Investors

AtriCure, Inc. (NASDAQ: ATRC), a key player in the healthcare sector specializing in medical instruments and supplies, is capturing investor interest with its promising growth prospects and strong analyst ratings...

Search

Funds

December 16, 2025

Search

Funds

December 16, 2025

FTSE 100

Funds